Obesity Intelligence & Analytics, Senior Director, Global Insights

Amgen's Mission of Serving Patients

At Amgen, if you feel like you're part of something bigger, it's because you are. Our shared mission—to serve patients living with serious illnesses—drives all that we do.

Since 1980, we've helped pioneer the world of biotech in our fight against the world's toughest diseases. With our focus on four therapeutic areas –Oncology, Inflammation, General Medicine, and Rare Disease– we reach millions of patients each year. Amgen is advancing a broad and deep pipeline of medicines to treat cancer, heart disease, inflammatory conditions, rare diseases, and obesity and obesity-related conditions.

As a member of the Amgen team, you'll help make a lasting impact on the lives of patients as we research, manufacture, and deliver innovative medicines to help people live longer, fuller happier lives.

Our award-winning culture is collaborative, innovative, and science based. If you have a passion for challenges and the opportunities that lay within them, you'll thrive as part of the Amgen team. Join us and transform the lives of patients while transforming your career.

The Senior Director, Global Insights, Obesity will lead the development and delivery of integrated commercial insights that shape the global strategy for Amgen's obesity portfolio, including Mari Tide, pipeline assets, and broader therapeutic area opportunities.

This individual will serve as the primary insights partner to the Global Obesity Program and will work closely with Commercial, Global Marketing, Medical, Clinical Development, and Value & Access. The role will establish and lead an integrated insights agenda that connects primary market research, secondary analytics, forecasting, competitive intelligence, and internal knowledge to inform therapeutic area, asset, and evidence-generation strategies.

The Senior Director will be a highly collaborative and influential business partner who can translate complex and evolving business questions into focused learning plans and actionable recommendations. The individual will proactively identify emerging opportunities and risks, challenge established thinking when appropriate, and help senior leaders make objective, evidence-based decisions in an environment characterized by significant uncertainty and rapid market evolution.

This role reports to the Executive Director, Obesity Intelligence & Analytics, Commercial and requires 3 days on campus.

• Serve as the senior insights partner for the Global Obesity Program, developing trusted relationships with global commercial leaders and cross-functional stakeholders across Mari Tide, pipeline assets, and the broader obesity therapeutic area.
• Establish and lead an integrated global insights agenda aligned with therapeutic area priorities, asset strategies, clinical development milestones, commercialization needs, and internal governance decisions.
• Lead the design and execution of primary market research across the product lifecycle, including early asset assessment, clinical development, target product profile optimization, positioning, segmentation, launch planning, lifecycle management, and indication expansion.
• Integrate primary research, secondary analytics, forecasting, competitive intelligence, advisory boards, real-world evidence, and internal expertise to develop a cohesive understanding of the market and its implications for Amgen.
• Partner with Forecasting, Analytics, Competitive Intelligence, Value & Access, Medical, and Clinical Development teams to ensure that insights are translated into aligned assumptions, scenarios, strategic choices, and business recommendations.
• Provide insight leadership for obesity therapeutic area strategy, including market development, patient and healthcare professional needs, treatment pathways, competitive evolution, portfolio opportunities, and potential future standards of care.
• Develop business cases, scenario analyses, strategic workshops, and senior-level narratives to support portfolio decisions, clinical development plans, investment prioritization, lifecycle strategy, and governance discussions.
• Translate complex findings into…